I G 213 Pill: blue, oval, 10mm
The pill with imprint I G 213 (Blue, Oval, 10mm) has been identified as Sertraline Hydrochloride 50 mg and is used for Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, Depression, and Post Traumatic Stress Disorder. It belongs to the drug class selective serotonin reuptake inhibitors and is not a controlled substance.
Images for I G 213




Sertraline Hydrochloride
- Imprint
- I G 213
- Strength
- 50 mg
- Color
- Blue
- Size
- 10.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Selective serotonin reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients
-
calcium phosphate dihydrate dibasic,
microcrystalline cellulose,
magnesium stearate,
sodium starch glycolate type A potato,
titanium dioxide,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
polysorbate 80,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00143-9655 (Discontinued) | West-Ward Pharmaceuticals |
31722-0213 | Camber Pharmaceuticals, Inc. |
68084-0181 (Discontinued) | Amerisource Health Services |
53002-1192 | Pharmedix (repackager) |
68071-0548 | Nucare Pharmaceuticals Inc. (repackager) |
68071-1317 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "I G 213"
More about sertraline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4,592)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: selective serotonin reuptake inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- Sertraline monograph
- Sertraline (FDA)
- Sertraline Capsule (FDA)
- Sertraline ER Tablets (FDA)
- Sertraline Oral Concentrate (FDA)
- Sertraline Oral Solution (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.